Hammad Zafar
Hospitalist · Iowa City, IANPI 1215451778
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.3% of the total across 164 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 33.3% of the total. 2025 is the largest year on record at $1,990, more than ten times the $13 reported in 2019. Among hospitalist clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 164 payments — averaging $30.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$1K
- Takeda Pharmaceuticals U.S.A., Inc.$429
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$261
- Aimmune Therapeutics, Inc.$233
- Phathom Pharmaceuticals, Inc.$147
- plus $1K from 18 others
What the payments were for
- Food & beverage$4,76896%
- Education$1844%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 74 | $1,650 |
| Johnson & Johnson | 29 | $1,068 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $429 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $261 |
| Aimmune Therapeutics, Inc. | 6 | $233 |
| Phathom Pharmaceuticals, Inc. | 2 | $147 |
| Sanofi | 3 | $139 |
| Gilead | 1 | $115 |
| E.r. Squibb & Sons, L.L.C. | 1 | $105 |
| Regeneron Healthcare Solutions, Inc. | 1 | $101 |
| Mirum Pharmaceuticals, Inc. | 1 | $100 |
| Janssen Scientific Affairs, LLC | 1 | $100 |
| Alnylam Pharmaceuticals Inc. | 1 | $89 |
| Ardelyx, Inc. | 3 | $68 |
| ERBE USA Inc | 1 | $65 |
| Intercept Pharmaceuticals, Inc. | 3 | $56 |
| Celltrion USA Inc. | 2 | $51 |
| Madrigal Pharmaceuticals | 3 | $49 |
| Ipsen Biopharmaceuticals, Inc | 1 | $25 |
| Axonics, Inc. | 1 | $25 |
| Orphalan Inc | 1 | $24 |
| Lilly USA, LLC | 1 | $21 |
| Coloplast | 1 | $18 |
| Bristol Myers Squibb | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,952 in reported general payments places this provider in the 95th percentile of 223 hospitalist providers in Iowa.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 20 | $302 |
| Omeprazole | 17 | $232 |
| Pantoprazole Sodium | 18 | $175 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Iowa City
- Robert DemuthIowa City$40K
- Eric HellerIowa City$25K
- Mehul AdhadukIowa City$2K
- Muhammad KhalidIowa City$876
- Jennifer GrayIowa City$759
- Robert LoveIowa City$681
- Ruchi SharmaIowa City$529
- Azaria EhlersIowa City$445
- Tilachan ParajuliIowa City$331
- Varun RajagopalanIowa City$279
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.